Cargando…
Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer
BACKGROUND: To assess the impact of PET/CT functional parameters on survival, locoregional, and distant failure according to the most distant level of lymph node [(18)F]FDG uptake in patients with locally advanced cervical cancer (LACC). METHODS: Retrospective study including 148 patients with LACC...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308355/ https://www.ncbi.nlm.nih.gov/pubmed/35870900 http://dx.doi.org/10.1186/s12885-022-09785-w |
_version_ | 1784752967462682624 |
---|---|
author | Martinez, Alejandra Chantalat, Elodie Angeles, Martina Aida Ferron, Gwénaël Ducassou, Anne Daix, Manon Attal, Justine Bétrian, Sarah Lusque, Amélie Gabiache, Erwan |
author_facet | Martinez, Alejandra Chantalat, Elodie Angeles, Martina Aida Ferron, Gwénaël Ducassou, Anne Daix, Manon Attal, Justine Bétrian, Sarah Lusque, Amélie Gabiache, Erwan |
author_sort | Martinez, Alejandra |
collection | PubMed |
description | BACKGROUND: To assess the impact of PET/CT functional parameters on survival, locoregional, and distant failure according to the most distant level of lymph node [(18)F]FDG uptake in patients with locally advanced cervical cancer (LACC). METHODS: Retrospective study including 148 patients with LACC treated with concurrent chemoradiotherapy after PET/CT and para-aortic lymph node (PALN) surgical staging. Two senior nuclear medicine physicians reviewed all PET/CT exams and retrieved tumor and lymph node metabolic parameters: SUVmax, MTV, TLG. Oncological outcomes according to metabolic parameters and level of lymph node spread on PET/CT were assessed. RESULTS: In patients without lymph node uptake on PET/CT, high MTV values of the cervical tumor were associated with DFS (HR = 5.14 95%CI = [2.15–12.31]), OS (HR = 6.10 95%CI = [1.89–19.70]), and time to distant (HR = 4.73 95%CI = [1.55–14.44]) and locoregional recurrence (HR = 5.18 95%CI = [1.72–15.60]). In patients with pelvic lymph node (PLN) uptake but without PALN uptake on [(18)F]FDG-PET/CT, high MTV values of the cervical tumor were associated with DFS (HR = 3.17 95%CI = [1.02–9.83]) and OS (HR = 3.46 95%CI = [0.96–12.50]), and the number of PLN fixations was associated with DFS (HR = 1.30 95%CI = [1.10–1.53]), OS (HR = 1.35 95%CI = [1.11–1.64]), and time to distant (HR = 1.35 95%CI = [1.08–1.67]) and locoregional recurrence (HR = 1.31 95%CI = [1.08–1.59]). There was no significant association between cervical tumor metabolic or lymph node metrics and survival outcome in patients with PALN uptake. CONCLUSIONS: Cervical MTV is more accurate than SUVmax to predict survival outcome in patients with locoregional disease confined to the pelvis and should be implemented in routine clinical practice. Prognostic value of metabolic metrics disappears with PALN uptake, which is associated with distant failure in nearly half of patients. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-9308355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93083552022-07-24 Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer Martinez, Alejandra Chantalat, Elodie Angeles, Martina Aida Ferron, Gwénaël Ducassou, Anne Daix, Manon Attal, Justine Bétrian, Sarah Lusque, Amélie Gabiache, Erwan BMC Cancer Research Article BACKGROUND: To assess the impact of PET/CT functional parameters on survival, locoregional, and distant failure according to the most distant level of lymph node [(18)F]FDG uptake in patients with locally advanced cervical cancer (LACC). METHODS: Retrospective study including 148 patients with LACC treated with concurrent chemoradiotherapy after PET/CT and para-aortic lymph node (PALN) surgical staging. Two senior nuclear medicine physicians reviewed all PET/CT exams and retrieved tumor and lymph node metabolic parameters: SUVmax, MTV, TLG. Oncological outcomes according to metabolic parameters and level of lymph node spread on PET/CT were assessed. RESULTS: In patients without lymph node uptake on PET/CT, high MTV values of the cervical tumor were associated with DFS (HR = 5.14 95%CI = [2.15–12.31]), OS (HR = 6.10 95%CI = [1.89–19.70]), and time to distant (HR = 4.73 95%CI = [1.55–14.44]) and locoregional recurrence (HR = 5.18 95%CI = [1.72–15.60]). In patients with pelvic lymph node (PLN) uptake but without PALN uptake on [(18)F]FDG-PET/CT, high MTV values of the cervical tumor were associated with DFS (HR = 3.17 95%CI = [1.02–9.83]) and OS (HR = 3.46 95%CI = [0.96–12.50]), and the number of PLN fixations was associated with DFS (HR = 1.30 95%CI = [1.10–1.53]), OS (HR = 1.35 95%CI = [1.11–1.64]), and time to distant (HR = 1.35 95%CI = [1.08–1.67]) and locoregional recurrence (HR = 1.31 95%CI = [1.08–1.59]). There was no significant association between cervical tumor metabolic or lymph node metrics and survival outcome in patients with PALN uptake. CONCLUSIONS: Cervical MTV is more accurate than SUVmax to predict survival outcome in patients with locoregional disease confined to the pelvis and should be implemented in routine clinical practice. Prognostic value of metabolic metrics disappears with PALN uptake, which is associated with distant failure in nearly half of patients. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2022-07-23 /pmc/articles/PMC9308355/ /pubmed/35870900 http://dx.doi.org/10.1186/s12885-022-09785-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Martinez, Alejandra Chantalat, Elodie Angeles, Martina Aida Ferron, Gwénaël Ducassou, Anne Daix, Manon Attal, Justine Bétrian, Sarah Lusque, Amélie Gabiache, Erwan Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer |
title | Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer |
title_full | Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer |
title_fullStr | Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer |
title_full_unstemmed | Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer |
title_short | Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer |
title_sort | metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308355/ https://www.ncbi.nlm.nih.gov/pubmed/35870900 http://dx.doi.org/10.1186/s12885-022-09785-w |
work_keys_str_mv | AT martinezalejandra metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer AT chantalatelodie metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer AT angelesmartinaaida metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer AT ferrongwenael metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer AT ducassouanne metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer AT daixmanon metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer AT attaljustine metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer AT betriansarah metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer AT lusqueamelie metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer AT gabiacheerwan metabolicactivitydeterminessurvivaldependingontheleveloflymphnodeinvolvementincervicalcancer |